Mayne Pharma Group Limited (ASX: MYX)

Company Profile – Formerly known as Halcygen Pharmaceuticals Limited, Mayne Pharma Group Limited (ASX: MYX) is involved in the operations of manufacturing and selling branded and generic pharmaceutical products worldwide. The company is currently located in 1538 Main North Road Salisbury South, Australia. Currently, Mr. Scott Richards is the CEO and Managing Director of the company.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report